Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
This introductory paragraph highlights how yearly drawdown data for index funds reveals cyclic risk patterns and guides more resilient investment choices.
25,260 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...
Adobe has been down over past year, testing investors' patience. This guide breaks down the root causes, outlines act...
Duke Energy now delivers a 3.4% yield as the Fed pivots, making the utility an appealing income stock for retirees. L...
IBM agreed to pay $17,077,043 to settle False Claims Act allegations tied to nondiscrimination obligations in federal...
The 2026 Trustees Report shows the 75-year funding gap widening and the retirement trust fund projected to run dry by...
A new NBER study ties political promises about loan forgiveness to bigger defaults and altered spending, underscoring...
QuantumScape and Honda announce a multi-year joint R&D pact to accelerate solid-state battery development, sending QS...
A political move surrounding a major AI stock has sparked a market spike and ethics questions. This report analyzes t...
Ripple is rolling out XRP-powered cross-border transfers across Indonesia, the Philippines, and Vietnam, a move that ...
When the Federal Reserve keeps rates unchanged, big retailers can swing on a dime. This article dives into why home d...
SpaceX's blockbuster IPO has turned volatile as market conditions cool on AI and space tech bets. The stock has retre...